Skip to content

Clinical trials

Phase 2/3 trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: Serbia Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20063
20072
20082
20091
20101
20112
20121
20151
20166
20174
20184
20194
20204
20226
20233
20242
20256

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting10
Terminated9
Active, not recruiting7
Unknown status6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC4
ACADIA Pharmaceuticals Inc.3
AbbVie3
Ethicare GmbH3
argenx3
Theravance Biopharma2
BioCryst Pharmaceuticals1
Biogen1
Boris Dzudovic1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colitis, Ulcerative7
Heart Failure5
Carcinoma, Non-Small-Cell Lung4
Inflammatory Bowel Diseases3
Cardiomyopathy, Dilated2
Crohn Disease2
Heart Defects, Congenital2
Lupus Erythematosus, Systemic2
Recurrence2
Acute Kidney Injury1

Trials

Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.